
West Pharmaceutical Services, Inc.
WSTWest Pharmaceutical Services, Inc. is a global leader in providing advanced specialized healthcare packaging and delivery systems. The company focuses on innovative containment and delivery solutions for injectable drugs, including drug containers, aseptic systems, and diagnostic components, serving the pharmaceutical and biotechnology industries worldwide.
Dividend History
Investors can expect a dividend payout of $0.22 per share, scheduled to be distributed in 12 days on February 4, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| February 4, 2026 | $0.22 | 2026-01-28 | 2026-01-28 |
| November 19, 2025 | $0.22 | 2025-11-12 | 2025-11-12 |
| August 6, 2025 | $0.21 | 2025-07-30 | 2025-07-30 |
| May 7, 2025 | $0.21 | 2025-04-30 | 2025-04-30 |
| February 11, 2025 | $0.21 | 2025-02-07 | 2025-02-07 |
Dividends Summary
- Consistent Payer: West Pharmaceutical Services, Inc. has rewarded shareholders with 89 dividend payments over the past 22 years.
- Total Returned Value: Investors who held WST shares during this period received a total of $13.91 per share in dividend income.
- Latest Payout: The most recent dividend of $0.22/share was paid 65 days ago, on November 19, 2025.
- Yield & Schedule: WST currently pays dividends quarterly with an annual yield of 0.35%.
- Dividend Growth: Since 2004, the dividend payout has grown by 4.8%, from $0.21 to $0.22.
- Dividend Reliability: WST has maintained or increased its dividend for 50 consecutive payments.
Company News
AbbVie announced a voluntary agreement with the Trump administration to lower drug prices for Medicaid while pledging $100 billion in U.S.-based R&D and capital investments over the next decade. In exchange, the company receives tariff exemptions and protection from future pricing mandates. AbbVie also announced a $650 million licensing deal with...
The global cell therapy packaging market is projected to grow from $404 million in 2025 to $1.22 billion by 2035, driven by personalized cell therapies and technological innovations in packaging solutions.
The global cell therapy packaging market is projected to grow from $419.57 million in 2025 to $1.27 billion by 2034, driven by increasing demand for cell and gene therapies, technological advancements, and specialized packaging solutions.
The global medical flexible packaging market is projected to grow from USD 21.48 billion in 2025 to USD 34.78 billion by 2034, with a 5.5% CAGR. Key growth drivers include rising pharmaceutical needs, sustainability focus, and increasing chronic disease prevalence.
West Pharmaceutical Services reported strong Q3 2025 earnings, beating analyst expectations with nearly 8% year-over-year sales growth and raising full-year guidance, leading to an 11% stock price increase.

